Edwards Lifesciences (EW) EBT Margin Growth (3y) (2012 - 2026)
Edwards Lifesciences (EW) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | -429.00 |
| 2 | Stryker | 129.62 Bn | 126.15 Bn | 4.50 Bn | 574.00 |
| 3 | Medtronic | 119.89 Bn | 110.67 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 74.01 Bn | 73.47 Bn | 3.85 Bn | 764.00 |
| 5 | Edwards Lifesciences | 52.48 Bn | 48.23 Bn | 1.35 Bn | 835.00 |
| 6 | Dexcom | 34.64 Bn | 32.69 Bn | 830.00 Mn | 598.00 |
| 7 | GE HealthCare Technologies | 33.90 Bn | 31.79 Bn | 2.18 Bn | 125.00 |
| 8 | Koninklijke Philips | 26.41 Bn | 23.09 Bn | 4.55 Bn | 631.00 |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn | 423.00 |
| 10 | Zimmer Biomet Holdings | 19.35 Bn | 18.94 Bn | 1.54 Bn | -309.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 835.00 |
| Mar 31, 2026 | -480.00 |
| Dec 31, 2025 | -4,341.00 |
| Sep 30, 2025 | -845.00 |
| Jun 30, 2025 | -770.00 |
| Mar 31, 2025 | -180.00 |
| Dec 31, 2024 | -15.00 |
| Sep 30, 2024 | -10.00 |
| Jun 30, 2024 | -1,160.00 |
| Mar 31, 2024 | -409.00 |
| Dec 31, 2023 | -89.00 |
| Sep 30, 2023 | -76.00 |
| Jun 30, 2023 | 3,969.00 |
| Mar 31, 2023 | 34.00 |
| Dec 31, 2022 | 2,230.00 |
| Sep 30, 2022 | 330.00 |
| Jun 30, 2022 | 886.00 |
| Mar 31, 2022 | 452.00 |
| Dec 31, 2021 | 2,848.00 |
| Sep 30, 2021 | 240.00 |